Semorinemab
Semorinemab Uses, Dosage, Side Effects, Food Interaction and all others data.
Semorinemab is under investigation in clinical trial NCT03289143 (A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease).
| Trade Name | Semorinemab |
| Generic | Semorinemab |
| Semorinemab Other Names | MTAU9937A, Semorinemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Semorinemab
